v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04674566 |
Full text link
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : May 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : May 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
m.dhaen@corat-therapeutics.com |
Registration date
Last imported at : Dec. 23, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
2020-12-19 |
Recruitment status
Last imported at : May 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
key inclusion criteria: - hospitalized for covid-19 illness for ≤72 hours - positive sars-cov-2 test by standard rt-pcr assay or equivalent test - presence of moderate to severe clinical signs indicative of moderate or severe illness with covid19 prior to study treatment key |
Exclusion criteria
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
- diagnosis of asymptomatic covid-19, mild covid-19, or critical covid-19 - in the opinion of the investigator, is not likely to survive for >48 hours beyond day 1 - new onset stroke or seizure disorder during hospitalization and prior to day 1 - history of relevant cns pathology or current relevant cns pathology |
Number of arms
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
5 |
Funding
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Corat Therapeutics Gmbh |
Inclusion age min
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : May 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Germany |
Type of patients
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
45 |
primary outcome
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Proportion of patients with Adverse Events of Special Interest (AESI);Proportion of patients with Serious Adverse Events (SAEs);Proportion of patients with Treatment-Emergent Adverse Events (TEAEs) |
Notes
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 1/Phase 2 |
Arms
Last imported at : Dec. 21, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "Low dose", "treatment_id": 323, "treatment_name": "Cor-101", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "mid dose 1", "treatment_id": 323, "treatment_name": "Cor-101", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "mid dose 2", "treatment_id": 323, "treatment_name": "Cor-101", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "high dose", "treatment_id": 323, "treatment_name": "Cor-101", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |